MEDICAMEQ.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Stats
本日の出来高	8 818.00
平均出来高	58 171.00
時価総額	6.57B
EPS	INR0 ( 2024-02-11 )
次の収益日	( INR0 ) 2024-05-27
Last Dividend	INR1.000 ( 2022-09-19 )
Next Dividend	INR0 ( N/A )
P/E	57.40
ATR14	INR1.433 (0.28%)

ボリューム相関

長: 0.09 (neutral)

短: 0.64 (weak)

Signal:(41.821) Neutral

Medicamen Biotech Limited 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Medicamen Biotech Limited 相関 - 通貨/商品

-0.22
( neutral )

-0.20
( neutral )

-0.15
( neutral )

-0.74
( moderate negative )

0.28
( neutral )

Medicamen Biotech Limited 財務諸表

Annual	2022
収益:	INR1.41B
総利益:	INR687.74M (48.82 %)
EPS:	INR11.92

FY	2022
収益:	INR1.41B
総利益:	INR687.74M (48.82 %)
EPS:	INR11.92

FY	2022
収益:	INR1.15B
総利益:	INR479.88M (41.57 %)
EPS:	INR12.19

FY	2021
収益:	INR1.13B
総利益:	INR335.16M (29.74 %)
EPS:	INR9.93

Financial Reports:

No articles found.

Medicamen Biotech Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Medicamen Biotech Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.57 - low (18.86%) | Divividend Growth Potential Score: 2.46 - Decrease likely (50.72%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2022-09-19
Last Dividend	INR1.000	2022-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	INR1.000	--
Avg. Dividend % Per Year	0.02%	--
Score	1.43	--
Div. Sustainability Score	3.57
Div.Growth Potential Score	2.46
Div. Directional Score	3.02	--

Next Divdend (Est)
(2024-05-08)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.43

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2022	INR1.000	0.10%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUPRAJIT.NS	Dividend Junior	2023-09-18	Semi-Annually	20	0.45%
NBIFIN.NS	Dividend Junior	2023-08-11	Sporadic	8	0.01%
HSCL.NS	Dividend Knight	2023-06-09	Annually	18	0.22%
CASTROLIND.NS	Dividend Knight	2023-08-08	Semi-Annually	22	4.14%
ROUTE.NS	Dividend Junior	2023-09-06	Semi-Annually	4	0.38%
LICHSGFIN.NS	Dividend Junior	2023-08-18	Annually	23	1.85%
GANDHITUBE.NS	Dividend Junior	2023-07-28	Annually	17	1.82%
APOLSINHOT.NS	Dividend Junior	2023-09-22	Annually	10	0.11%
TDPOWERSYS.NS	Dividend Junior	2023-08-02	Annually	13	0.31%
OLECTRA.NS	Dividend Junior	2023-09-21	Sporadic	23	0.03%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0671	1.500	8.66	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0582	1.500	-0.464	-0.696	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	5.27	1.000	9.16	9.16	[3 - 30]
operatingCashFlowPerShareTTM	10.97	2.00	6.34	10.00	[0 - 30]
freeCashFlowPerShareTTM	10.97	2.00	4.51	9.03	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.469	1.000	5.52	5.52	[0.2 - 0.8]
operatingProfitMarginTTM	0.104	1.000	9.92	9.92	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	57.77	1.000	4.27	0	[1 - 100]
returnOnEquityTTM	0.0582	2.50	-0.298	-0.696	[0.1 - 1.5]
freeCashFlowPerShareTTM	10.97	2.00	6.34	9.03	[0 - 30]
dividendYielPercentageTTM	0.191	1.500	5.22	0	[0 - 0.4]
operatingCashFlowPerShareTTM	10.97	2.00	6.34	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.124	1.500	-4.16	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0814	1.000	-0.466	0	[0.1 - 0.5]
Total Score				2.46

Medicamen Biotech Limited

Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.